Patent · US Active

Formulations of terlipressin

US12156898B2 · kind B2 · utility

0Cited by

2References

18Claims

0Family size

Assignee

BioVie, Inc. · US

Inventors

Penelope Markham · Clifton, US
Jonathan Adams · Chicago, US
Denise Smith · Buffalo Grove, US
Jorge Bacardit Cabado · Girona, ES

Key dates

Filing date	May 22, 2020
Grant date	Dec 3, 2024
Priority date	—
Expiry date	Apr 22, 2041

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61M5/14248
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

The disclosure provides pharmaceutical compositions comprising terlipressin having increased concentration with long term storage stability.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.